Select Publications
Book Chapters
2019, 'Descriptive and Drug Utilization Studies', in Babar Z-U-D (ed.), Encyclopedia of Pharmacy Practice and Clinical Pharmacy, ACADEMIC PR INC, pp. 344 - 355, http://dx.doi.org/10.1016/b978-0-128-12735-3.00027-3
,2019, 'Descriptive and Drug Utilization Studies', in Encyclopedia of Pharmacy Practice and Clinical Pharmacy: Volumes 1-3, pp. 344 - 355, http://dx.doi.org/10.1016/B978-0-12-812735-3.00202-8
,2017, 'Drug Pharmacology and Pharmacotherapy Treatments', in Ritter A; King T; Lee N (ed.), Drug Use and Australian Society 2nd Edition, OUP
,2010, 'Case 24: Neurologic and Psychotropic', in Chen T; Moles R; Basger B; Nishtala P (ed.), Case Studies in Practice: Medication Review: A Process Guide for Pharmacists
,2010, 'Case 25: Psychotropic, Cardiovascular, Endocrine, Respiratory, Gastrointestinal and Neurological', in Chen T; Moles R; Basger B; Nishtala P (ed.), Case Studies in Practice: Medication Review: A Process Guide for Pharmacists
,Journal articles
2024, 'Establishing mental health friendly pharmacies to assist in the early identification and support of older adults at risk of depression: The EMPATHISE pilot study', Journal of the American Pharmacists Association, 64, http://dx.doi.org/10.1016/j.japh.2024.102199
,2024, 'Trends in substance use and related harms among older adults in high-income countries', Addiction, 119, pp. 1676 - 1678, http://dx.doi.org/10.1111/add.16469
,2024, 'Long-term prescribed opioid use after hospitalization or emergency department presentation among opioid naïve adults (2014–2020)—A population-based descriptive cohort study', British Journal of Clinical Pharmacology, 90, pp. 2111 - 2123, http://dx.doi.org/10.1111/bcp.16093
,2024, 'Trajectories of Opioid Use Before and After Cancer Diagnosis: A Population-Based Cohort Study', Journal of Pain and Symptom Management, 68, pp. 282 - 291.e11, http://dx.doi.org/10.1016/j.jpainsymman.2024.06.006
,2024, 'The Medicines Intelligence Data Platform: A Population-Based Data Resource From New South Wales, Australia', Pharmacoepidemiology and Drug Safety, 33, http://dx.doi.org/10.1002/pds.5887
,2024, 'Oxycodone initiation in Australia (2014–2018): Sociodemographic factors and preceding health service use', British Journal of Clinical Pharmacology, 90, pp. 1656 - 1666, http://dx.doi.org/10.1111/bcp.16063
,2024, 'Prevalence and Persistence of Prescription Opioid Use Following Hospital Discharge after Childbirth: An Australian Population-Based Cohort Study', Anesthesia and Analgesia, 138, pp. 970 - 979, http://dx.doi.org/10.1213/ANE.0000000000006582
,2024, 'The accessibility of pharmacist prescribing and impacts on medicines access: A systematic review', Research in Social and Administrative Pharmacy, 20, pp. 475 - 486, http://dx.doi.org/10.1016/j.sapharm.2024.01.006
,2024, 'Age-Related Risk of Serious Fall Events and Opioid Analgesic Use', JAMA Internal Medicine, 184, pp. 394 - 401, http://dx.doi.org/10.1001/jamainternmed.2023.8154
,2024, 'The impact of tightened prescribing restrictions for PBS-subsidised opioid medicines and the introduction of half-pack sizes, Australia, 2020–21: an interrupted time series analysis', Medical Journal of Australia, 220, pp. 315 - 322, http://dx.doi.org/10.5694/mja2.52257
,2024, 'Age, period, and cohort trends of substance poisoning, alcohol-related disease, and suicide deaths in Australia, 1980–2019', Social Psychiatry and Psychiatric Epidemiology, http://dx.doi.org/10.1007/s00127-024-02749-4
,2024, 'Prescription opioid use among people with opioid dependence and concurrent benzodiazepine and gabapentinoid exposure: An analysis of overdose and all-cause mortality', International Journal of Drug Policy, 123, http://dx.doi.org/10.1016/j.drugpo.2023.104287
,2024, 'Trends in use of medicines for opioid agonist treatment in Australia, 2013–2022', International Journal of Drug Policy, 123, http://dx.doi.org/10.1016/j.drugpo.2023.104255
,2024, 'Association of Opioid Analgesics, Benzodiazepines, Gabapentinoids, and Opioid Agonist Treatment With Mortality Among Individuals With Opioid Dependence', Drug and Alcohol Dependence, 260, pp. 110845 - 110845, http://dx.doi.org/10.1016/j.drugalcdep.2023.110845
,2024, 'Prevalence of Comorbid Substance Use Disorders Among People With Opioid Use Disorder: A Systematic Review and Meta-Analysis', Drug and Alcohol Dependence, 260, pp. 110148 - 110148, http://dx.doi.org/10.1016/j.drugalcdep.2023.110148
,2023, 'Impact of a pharmacy-led screening and intervention in people at risk of or living with chronic kidney disease in a primary care setting: A cluster randomised trial protocol', BMJ Open, 13, http://dx.doi.org/10.1136/bmjopen-2023-079110
,2023, 'Community pharmacists’ acceptability of pharmacist-delivered depression screening for older adults: a qualitative study', International Journal of Clinical Pharmacy, 45, pp. 1144 - 1152, http://dx.doi.org/10.1007/s11096-023-01581-1
,2023, 'All-cause and cause-specific mortality in individuals with an alcohol-related emergency or hospital inpatient presentation: A retrospective data linkage cohort study', Addiction, 118, pp. 1751 - 1762, http://dx.doi.org/10.1111/add.16218
,2023, 'Mortality during and after specialist alcohol and other drug treatment: Variation in rates according to principal drug of concern and treatment modality', Drug and Alcohol Review, 42, pp. 1461 - 1471, http://dx.doi.org/10.1111/dar.13669
,2023, 'Opioid prescribing patterns among medical practitioners in New South Wales, Australia', Drug and Alcohol Review, 42, pp. 1472 - 1481, http://dx.doi.org/10.1111/dar.13675
,2023, 'Five-Year Trajectories of Prescription Opioid Use', JAMA Network Open, 6, pp. E2328159, http://dx.doi.org/10.1001/jamanetworkopen.2023.28159
,2023, 'Cohort profile: POPPY II - A population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia', BMJ Open, 13, http://dx.doi.org/10.1136/bmjopen-2022-068310
,2023, 'Incidence of suicide and self-harm among people with opioid use disorder and the impact of opioid agonist treatment: A retrospective data linkage study', Drug and Alcohol Dependence, 246, http://dx.doi.org/10.1016/j.drugalcdep.2023.109851
,2023, 'A data-informed approach using individualised dispensing patterns to estimate medicine exposure periods and dose from pharmaceutical claims data', Pharmacoepidemiology and Drug Safety, 32, pp. 352 - 365, http://dx.doi.org/10.1002/pds.5567
,2023, 'The effects of childhood trauma and mental disorders on treatment engagement, contact with the criminal justice system, and mortality among people with opioid dependence', Drug and Alcohol Dependence, 243, http://dx.doi.org/10.1016/j.drugalcdep.2022.109734
,2023, 'Editorial: Women in pharmacoepidemiology: 2021', Frontiers in Pharmacology, 14, http://dx.doi.org/10.3389/fphar.2023.1278768
,2023, 'Community pharmacists’ acceptability of screening for depression among older adults: A qualitative study', Research in Social and Administrative Pharmacy, 19, pp. 14 - 14, http://dx.doi.org/10.1016/j.sapharm.2023.04.041
,2023, 'Evaluating informal caregivers’ needs in managing medicines for people receiving cancer treatment in Australia', Research in Social and Administrative Pharmacy, 19, pp. 5 - 5, http://dx.doi.org/10.1016/j.sapharm.2023.04.013
,2022, '“Frustrated with the whole system”: a qualitative framework analysis of the issues faced by people accessing health services for chronic pain', BMC Health Services Research, 22, http://dx.doi.org/10.1186/s12913-022-08946-8
,2022, 'Age at first alcohol-related hospital separation or emergency department presentation and rate of re-admission: A retrospective data linkage cohort of young Australians', Drug and Alcohol Review, 41, pp. 1577 - 1588, http://dx.doi.org/10.1111/dar.13529
,2022, 'Trends in pharmaceutical opioid consumption in the WHO Eastern Mediterranean Region, 2010–2019', Eastern Mediterranean Health Journal, 28, pp. 788 - 797, http://dx.doi.org/10.26719/emhj.22.085
,2022, 'Prevalence of mental disorders among people with opioid use disorder: A systematic review and meta-analysis', Drug and Alcohol Dependence, 238, http://dx.doi.org/10.1016/j.drugalcdep.2022.109551
,2022, 'Trends in opioid analgesic utilisation among people with a history of opioid dependence', Drug and Alcohol Dependence, 238, http://dx.doi.org/10.1016/j.drugalcdep.2022.109548
,2022, 'Self-reported challenges obtaining ongoing prescription opioids among Australians with chronic non-cancer pain', International Journal of Drug Policy, 105, http://dx.doi.org/10.1016/j.drugpo.2022.103708
,2022, 'Use of pharmacological and nonpharmacological treatments for chronic noncancer pain among people using opioids: a longitudinal cohort study', Pain, 163, pp. 1049 - 1059, http://dx.doi.org/10.1097/j.pain.0000000000002484
,2022, 'Trends in transdermal fentanyl utilisation and fatal fentanyl overdose across Australia (2003–2015)', Drug and Alcohol Review, 41, pp. 435 - 443, http://dx.doi.org/10.1111/dar.13391
,2022, 'Exposure to childhood trauma increases risk of opioid use disorder among people prescribed opioids for chronic non-cancer pain', Drug and Alcohol Dependence, 230, http://dx.doi.org/10.1016/j.drugalcdep.2021.109199
,2021, 'The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15-year retrospective cohort study', Addiction, 116, pp. 3139 - 3152, http://dx.doi.org/10.1111/add.15514
,2021, 'Variations in Long-term Opioid Therapy Definitions: A Systematic Review of Observational Studies Using Routinely Collected Data (2000-2019)', British Journal of Clinical Pharmacology, 87, pp. 3706 - 3720, http://dx.doi.org/10.1111/bcp.14798
,2021, '1045Patterns, predictors and outcomes of opioid use in Australia: evidence for an epidemic?', International Journal of Epidemiology, 50, http://dx.doi.org/10.1093/ije/dyab168.309
,2021, 'Clinical correlates and outcomes associated with pregabalin use among people prescribed opioids for chronic non-cancer pain: A five-year prospective cohort study', British Journal of Clinical Pharmacology, 87, pp. 3092 - 3104, http://dx.doi.org/10.1111/bcp.14715
,2021, 'Trends and characteristics of extra-medical use of quetiapine among people who regularly inject drugs in Australia, 2011–2018', Drug and Alcohol Dependence, 221, http://dx.doi.org/10.1016/j.drugalcdep.2021.108636
,2021, 'Prevalence of childhood maltreatment among people with opioid use disorder: A systematic review and meta-analysis', Drug and Alcohol Dependence, 219, http://dx.doi.org/10.1016/j.drugalcdep.2020.108459
,2020, 'Extra-medical use of antipsychotics: what can be learnt from experiences with other prescription medicines?', Addiction, 115, pp. 1203 - 1205, http://dx.doi.org/10.1111/add.14823
,2020, 'Patterns and correlates of prescribed and non-prescribed pregabalin use among a sample of people who inject drugs in Australia', Drug and Alcohol Review, 39, pp. 568 - 574, http://dx.doi.org/10.1111/dar.13083
,